Top Markets
Coin of the day
Patient Access Solutions, Inc. Patient Access Solutions, Inc.

Patient Access Solutions, Inc.

PASO
Clasificación en acciones #40839
Patient Access Solutions, Inc. (PASO) specializes in providing comprehensive... Patient Access Solutions, Inc. (PASO) specializes in providing comprehensive financial and administrative processing solutions tailored for the medical and dental sectors. Utilizing its proprietary merchant processing platform, the company facilitates essential services such as patient eligibility verification, streamlined medical billing, and flexible patient self-pay options. Beyond its core payment solutions, PASO offers a range of consultative and operational support, including detailed practice management assistance, strategic business consulting, thorough GAP analyses, and initiatives for marketing and practice development. The firm further diversifies its offerings with therapeutic interventions for conditions like autism, concussion, and PTSD, alongside other biomedical disorders, complemented by a suite of diagnostic testing services. Patient Access Solutions, Inc. is headquartered in Plainview, New York.
Precio por acción
$0.0001
Última sincronización: 2026-08-12
Capitalización bursátil
$74.06K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Patient Access Solutions, Inc. (PASO)

Categoría

Ganancias de Patient Access Solutions, Inc. (PASO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Patient Access Solutions, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Patient Access Solutions, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$2.04B -
US
$222.34M -
AU
$295.53M -
US
$-259.89M -
US
- -
US